New York State Common Retirement Fund
ATXI

New York State Common Retirement Fund’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

New York State Common Retirement Fund’s Portfolio ATXI Stock Details ATXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Hold
0
– – – 3552
2021
Q2 		– Sell
-6
Closed -$29.6K – 3576
2021
Q1 		$41K Hold
6
– – ﹤0.01% 3247
2020
Q4 		$40K Hold
6
– – ﹤0.01% 3214
2020
Q3 		$74K Sell
6
-2
-25% -$24.3K ﹤0.01% 3050
2020
Q2 		$97K Buy
+8
New +$90.3K ﹤0.01% 2976

Other funds holding ATXI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

New York State Common Retirement Fund's ATXI Position: Q3 2021 in Review

New York State Common Retirement Fund held its Avenue Therapeutics, Inc. Common Stock (ATXI) position steady in Q3 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3552.

New York State Common Retirement Fund first reported a position in ATXI in Q2 2020 and has held it in 4 quarters since. The position peaked at $97K in Q2 2020. 17 funds tracked by Wall St. Rank hold ATXI as of Q3 2021.

  • New York State Common Retirement Fund held 0 shares of Avenue Therapeutics, Inc. Common Stock worth $0 as of Q3 2021.
  • New York State Common Retirement Fund left its Avenue Therapeutics, Inc. Common Stock share count unchanged in Q3 2021.
  • Avenue Therapeutics, Inc. Common Stock made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q3 2021, its #3552 holding.
  • New York State Common Retirement Fund first reported a position in Avenue Therapeutics, Inc. Common Stock in Q2 2020 and has held it in 4 quarters since.
  • New York State Common Retirement Fund's Avenue Therapeutics, Inc. Common Stock position peaked at $97K in Q2 2020.
  • 17 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.